Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma

Surgery

Volumn 139, Issue 5, 2006, Pages 678-685

  Honma, Hideyuki ^a   Kanda, Tatsuo ^a   Ito, Hiroaki ^a   Wakai, Toshifumi ^a   Nakagawa, Satoru ^a   Ohashi, Manabu ^a   Koyama, Yu ^a   Valera, Vladimir A ^a   Akazawa, Kouhei ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

AGED; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; SURVIVAL ANALYSIS;

EID: 33646419021     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.09.022     Document Type: Article

References (44)

1. Soeth E., Vogel I., Röder C., et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57 (1997) 3106-3110
2. Hardingham J.E., Hewett P.J., Sage R.E., et al. Molecular detection of blood borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 89 (2000) 8-13
3. Taniguchi T., Makino M., Suzuki K., et al. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89 (2000) 970-976
4. Kaganoi J., Shimada Y., Kano M., et al. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg 91 (2004) 1055-1060
5. Yamaguchi K., Takagi Y., Aoki S., et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232 (2000) 58-65
6. Schmitz-Winnenthal F.H., Weckauf H., Haufe S., et al. Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR. Surgery 134 (2003) 964-972
7. Jotsuka T., Okumura Y., Nakano S., et al. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse. a prospective study in node-negative breast cancer. Surgery 135 (2004) 419-426
8. Nakashima S., Natsugoe S., Matsumoto M., et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery 133 (2003) 162-169
9. Sadahiro S., Suzuki T., Tokunaga N., et al. Detection of tumor cells in portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction. Cancer 92 (2001) 1251-1258
10. Wyld D.K., Selby P., Perren T.J., et al. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79 (1998) 288-293
11. Witzigmann H., Geissler F., Benedix F., et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 131 (2002) 34-43
12. Douard R., Le Maire V., Wind P., et al. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients. Surgery 129 (2001) 587-594
13. Kurusu Y., Yamashita J., and Ogawa M. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery 126 (1999) 820-826
14. Patel H., Le Marer N., Wharton R.Q., et al. Clearance of circulating tumor cells after excision of primary colorectal cancer. Ann Surg 235 (2002) 226-231
15. Ito H., Kanda T., Nishimaki T., et al. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. J Exp Clin Cancer Res 3 (2004) 455-464
16. Thorban S., Roder J.D., Pantel K., et al. Epithelial tumor cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 32A (1996) 363-365
17. Roder J.D., Thorban S., Pantel K., et al. Micrometastases in bone marrow. prognostic indicators for pancreatic cancer. World J Surg 23 (1999) 888-891
18. Thorban S., Roder J.D., and Siewert J.R. Detection of micrometastasis in bone marrow of pancreatic cancer patients. Ann Oncol 10 Suppl 4 (1999) 111-113
19. Z'graggen K., Centeno B.A., Fernandez-delCastillo C., et al. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. Surgery 129 (2001) 537-546
20. Vogel I., and Kalthoff H. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 439 (2001) 109-117
21. Raper S.R. Answering questions on a microscopic scale. the detection of circulating cancer cells. Surgery 126 (1999) 827-828
22. Heid C.A., Stevens J., Livak K.J., et al. Real time quantitative PCR. Genome Res 6 (1996) 986-994
23. Gibson U.E., Heid C.A., and Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res 6 (1996) 995-1001
24. Kato H., and Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40 (1977) 1621-1628
25. Shimada H., Nabeya Y., Okazumi S., et al. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 133 (2003) 486-494
26. Mino N., Iio A., and Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 62 (1988) 730-734
27. Kato H., Morioka H., Tsutsui H., et al. Value of tumor antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 50 (1982) 1294-1296
28. Duk J.M., Groenier K.H., de Bruijn H.W., et al. Pretreatment serum squamous cell carcinoma antigen. a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol 14 (1996) 111-118
29. Bolger B.S., Dabbas M., Lopes A., et al. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 65 (1997) 309-313
30. Kosugi S., Nishimaki T., Kanda T., et al. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg 28 (2004) 680-685
31. Sobin L.H., and Wittekind C.H. UICC TNM classification of malignant tumours. 6th ed. (2002), John Wiley&Sons, Inc, New York
32. Schneider S.S., Schick C., Fish K.E., et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A 92 (1995) 3147-3151
33. Koike A. Mechanism of blood-borne metastases. Cancer 17 (1964) 450-460
34. Mayhew E., and Glaves D. Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer 50 (1984) 159-166
35. Kano M., Shimada Y., Kaganoi J., et al. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA. Br J Cancer 82 (2000) 429-435
36. Nakashima S., Natsugoe S., Matsumoto M., et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery 133 (2003) 162-169
37. Kato H., Miyazaki T., Nakajima M., et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 91 (2004) 1004-1009
38. van Westreenen H.L., Westerterp M., Bossuyt P.M., et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 (2004) 3805-3812
39. Larson S.M., Schoder H., and Yeung H. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer. Cancer J 10 (2004) 243-250
40. Rohren E.M., Turkington T.G., and Coleman R.E. Clinical applications of PET in oncology. Clinical applications of PET in oncology. Radiology 231 (2004) 305-332
41. Koshy M., Esiashvilli N., Landry J.C., et al. Multiple management modalities in esophageal cancer. epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist 9 (2004) 137-146
42. Weinberg J.S., Suki D., Hanbali F., et al. Metastasis of esophageal carcinoma to the brain. Cancer 98 (2003) 1925-1933
43. Ogawa K., Toita T., Sueyama H., et al. Brain metastases from esophageal carcinoma. natural history, prognostic factors, and outcome. Cancer 94 (2002) 759-764
44. Gabrielsen T.O., Eldevik O.P., Orringer M.B., et al. Esophageal carcinoma metastatic to the brain. clinical value and cost-effectiveness of routine enhanced head CT before esophagectomy. AJNR Am J Neuroradiol 16 (1995) 1915-1921